CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
VBMIbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02823457
NCT02823457N/ACompleted
CompareCT.gov

Evaluating Values-based Motivational Interviewing to Increase Treatment Completion With Fixed Dose Combination MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders and Treatment-naïve Genotype 1 Chronic Hepatitis C

G.V. (Sonny) Montgomery VA Medical Center·interventional·Posted Jul 6, 2016·Updated Jan 18, 2022

In Brief

A clinical study evaluating VBMI for Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This study implement a values-based motivational interviewing (VBMI) intervention to promote treatment completion with fixed dose combination (FDC) MK-5172/MK-8742 x 12 weeks among 30 Veterans with substance use disorder (SUD) and treatment naïve genotype 1 chronic hepatitis C virus (HCV) infection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPatient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 6, 2016
Enrollment StartApr 5, 2017
Primary CompletionJan 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.0 years ago

Interventions

VBMIbehavioral

12 week values based motivational interviewing intervention with a licensed psychologist